May 21, 2021
A new study published in The Lancet shows the results of Phase 2a and Phase 3 clinical trials for the effectiveness of mTOR inhibition to bolster the aging immune system against respiratory illnesses. Immunosenescence increases disease risk As we grow older, our immune systems become increasingly dysfunctional and less able to defend us from the...